Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Sponsor: Eli Lilly and Company
Summary
The purpose of this study is to test the efficacy and safety of orforglipron in participants with T2D (type 2 diabetes) who participate in fasting during Ramadan. For each participant, the study will last up to 48 weeks with a minimum of 7 in clinic visits and 4 virtual visits.
Official title: A Phase 3b, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Orforglipron in Adult Participants With Type 2 Diabetes Who Observe Ramadan Fasting (ACHIEVE-RAM)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
130
Start Date
2026-07
Completion Date
2027-05
Last Updated
2026-06-23
Healthy Volunteers
No
Conditions
Interventions
Orforglipron
Administered orally
Locations (37)
Sarojini Naidu Medical College
Agra, India
Osmania General Hospital
Hyderabad, India
Brij Medical Centre Pvt. Ltd.
Kanpur, India
Apollo Multispeciality Hospitals limited
Kolkata, India
KGN Diabetes and Endocrinology Centre
Mumbai, India
Mysore Medical College and Research Institute
Mysore, India
Supe Heart & Diabetes Hospital & Research Centre
Nashik, India
Diabetes Clinic
Nellore, India
Visakha Institute of Medical Sciences
Visakhapatna, India
King Abdulaziz University for Health Sciences Ministry of National Guard Health Affairs
Al-Ahsa, Saudi Arabia
King Fahad Specialist Hospital
Dammam, Saudi Arabia
National Guard Health Affairs: King Abdulaziz Medical City
Jeddah, Saudi Arabia
Dr. Soliman Fakeeh Hospital
Jeddah, Saudi Arabia
King Abdulaziz University Hospital
Jeddah, Saudi Arabia
King Fahad Armed Forces Hospital Jeddah
Jeddah, Saudi Arabia
King Saud University Medical City
Riyadh, Saudi Arabia
Dr. Soliman Fakeeh Hospital
Riyadh, Saudi Arabia
Osepdale Fatebenefratelli e Oftalmico
Riyadh, Saudi Arabia
JOSHA Research
Bloemfontein, South Africa
TREAD Research
Cape Town, South Africa
TASK Central
Cape Town, South Africa
Tiervlei Trial Centre
Cape Town, South Africa
Synopsis Research
Cape Town, South Africa
Synergy Biomed Research Institute (SBRI)
East London, South Africa
Aliwal Shoal Medical Centre
eMkhomazi, South Africa
Fola Health
Johannesburg, South Africa
Trident Clinical
Kimberley, South Africa
Ubuntu Clinical Research Krugersdorp
Krugersdorp, South Africa
Drs H & V Makan Centre for Diabetes
Lenasia, South Africa
Be Part Research (PTY) LTD
Paarl, South Africa
Emmed Research
Pretoria, South Africa
Dr JM Engelbrecht Trial Site
Somerset West, South Africa
Sheikh Khalifa Medical City
Abu Dhabi, United Arab Emirates
NMC Abu Dhabi
Abu Dhabi, United Arab Emirates
Tawam Hospital
Al Ain City, United Arab Emirates
Emirates Hospital Dubai
Dubai, United Arab Emirates
Dubai Hospital
Dubai, United Arab Emirates